ZA200904713B - Punctal plugs and methods of delivering therapeutic agents - Google Patents

Punctal plugs and methods of delivering therapeutic agents

Info

Publication number
ZA200904713B
ZA200904713B ZA200904713A ZA200904713A ZA200904713B ZA 200904713 B ZA200904713 B ZA 200904713B ZA 200904713 A ZA200904713 A ZA 200904713A ZA 200904713 A ZA200904713 A ZA 200904713A ZA 200904713 B ZA200904713 B ZA 200904713B
Authority
ZA
South Africa
Prior art keywords
methods
therapeutic agents
delivering therapeutic
punctal plugs
punctal
Prior art date
Application number
ZA200904713A
Inventor
Theron R Rodstrom
Larry Ii Smith
Youqin Tian
David Allen Marsh
Alan L Weiner
Shivalik Bakshi
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of ZA200904713B publication Critical patent/ZA200904713B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
ZA200904713A 2007-01-31 2008-01-30 Punctal plugs and methods of delivering therapeutic agents ZA200904713B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89859907P 2007-01-31 2007-01-31

Publications (1)

Publication Number Publication Date
ZA200904713B true ZA200904713B (en) 2010-09-29

Family

ID=39313204

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904713A ZA200904713B (en) 2007-01-31 2008-01-30 Punctal plugs and methods of delivering therapeutic agents

Country Status (24)

Country Link
US (1) US8753666B2 (en)
EP (1) EP2114531B1 (en)
JP (1) JP2010517630A (en)
KR (1) KR20090104099A (en)
CN (1) CN101600476B (en)
AR (1) AR065235A1 (en)
AU (1) AU2008210541B2 (en)
BR (1) BRPI0807340A2 (en)
CA (1) CA2674913A1 (en)
CL (1) CL2008000306A1 (en)
CY (1) CY1113075T1 (en)
DK (1) DK2114531T3 (en)
ES (1) ES2390991T3 (en)
HK (1) HK1133218A1 (en)
HR (1) HRP20120608T1 (en)
MX (1) MX2009007394A (en)
PL (1) PL2114531T3 (en)
PT (1) PT2114531E (en)
RU (1) RU2459646C2 (en)
SI (1) SI2114531T1 (en)
TW (1) TW200838485A (en)
UY (1) UY30883A1 (en)
WO (1) WO2008094989A2 (en)
ZA (1) ZA200904713B (en)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
EP3093040A1 (en) 2004-07-02 2016-11-16 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
CA2833354C (en) 2006-03-14 2015-12-15 University Of Southern California Mems device and method for delivery of therapeutic agents
NZ571758A (en) 2006-03-31 2012-06-29 Quadra Logic Tech Inc A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
CN101861135A (en) 2007-09-07 2010-10-13 Qlt栓塞输送公司 Lacrimal implant detection
WO2009035562A2 (en) 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Drug cores for sustained release of therapeutic agents
DK2865361T3 (en) 2007-09-07 2019-07-08 Mati Therapeutics Inc TEA REPLACEMENTS AND RELATED PROCEDURES
ES2425769T5 (en) 2007-12-20 2017-07-28 University Of Southern California Apparatus for the administration of therapeutic agents
EP2240220B1 (en) 2008-01-03 2016-04-13 University Of Southern California Implantable drug-delivery devices, and apparatus for refilling the devices
WO2009134371A2 (en) 2008-04-30 2009-11-05 Qlt Plug Delivery, Inc. Composite lacrimal insert and related methods
CN102202706A (en) * 2008-05-08 2011-09-28 迷你泵有限责任公司 Implantable drug-delivery devices, and apparatus and methods for filling the devices
EP2891501B1 (en) 2008-05-08 2016-09-21 MiniPumps, LLC Methods of manufacture of drug-delivery pumps
CN104353150A (en) 2008-05-08 2015-02-18 迷你泵有限责任公司 Implantable pums and cannulas therefor
US9199035B2 (en) 2008-05-08 2015-12-01 Minipumps, Llc. Drug-delivery pumps with dynamic, adaptive control
US9333297B2 (en) 2008-05-08 2016-05-10 Minipumps, Llc Drug-delivery pump with intelligent control
CN102123713A (en) * 2008-05-09 2011-07-13 Qlt栓塞输送公司 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
CN102105118A (en) * 2008-06-24 2011-06-22 Qlt栓塞输送公司 Combination treatment of glaucoma
US20100104654A1 (en) * 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP2012512725A (en) * 2008-12-19 2012-06-07 キュー エル ティー インク． Puncture implant for substance delivery and substance delivery method
MX2011007804A (en) * 2009-01-23 2011-12-06 Quadra Logic Tech Inc Sustained released delivery of one or more agents.
CN104887389B (en) 2009-01-29 2017-06-23 弗赛特影像4股份有限公司 Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
JP5576405B2 (en) * 2009-02-23 2014-08-20 キュー エル ティー インク． Lacrimal implant and related methods
US20100226962A1 (en) * 2009-03-03 2010-09-09 Rodstrom Theron R Peri-corneal drug delivery device
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
TWI495459B (en) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US20120078362A1 (en) * 2009-05-18 2012-03-29 Dose Medical Corporation Drug eluting ocular implant
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
WO2010151269A1 (en) 2009-06-26 2010-12-29 Biotic Laboratories, Inc. Para-xylylene based multilayer drug elution devices
WO2011094170A1 (en) 2010-01-27 2011-08-04 Alcon Research, Ltd. Pulsatile peri-corneal drug delivery device
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259352B2 (en) * 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
KR20130086131A (en) * 2010-04-06 2013-07-31 알러간, 인코포레이티드 Sustained-release reservoir implants for intracameral drug delivery
US9492315B2 (en) * 2010-08-05 2016-11-15 Forsight Vision4, Inc. Implantable therapeutic device
AU2011285548B2 (en) 2010-08-05 2014-02-06 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
DK2600930T3 (en) 2010-08-05 2021-03-01 Forsight Vision4 Inc Injection device for drug delivery
US8591484B2 (en) 2010-09-15 2013-11-26 AlphaMed, Inc. Lacrimal punctum measurement and occlusion
WO2012068549A2 (en) 2010-11-19 2012-05-24 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US9919099B2 (en) 2011-03-14 2018-03-20 Minipumps, Llc Implantable drug pumps and refill devices therefor
US9603997B2 (en) 2011-03-14 2017-03-28 Minipumps, Llc Implantable drug pumps and refill devices therefor
US10286146B2 (en) 2011-03-14 2019-05-14 Minipumps, Llc Implantable drug pumps and refill devices therefor
EP2701682A1 (en) 2011-04-29 2014-03-05 Allergan, Inc. Solvent cast film sustained release latanoprost implant
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
US20130018360A1 (en) * 2011-07-13 2013-01-17 Marissa Dockendorf Method for delivering ophthalmic drugs
EP2739252A4 (en) 2011-08-05 2015-08-12 Forsight Vision4 Inc Small molecule delivery with implantable therapeutic device
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
EP2750660B1 (en) 2011-08-29 2016-10-12 Mati Therapeutics Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
CN103917202B (en) 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 Eye insert apparatus and method
PL2755600T3 (en) 2011-09-16 2021-09-20 Forsight Vision4, Inc. Fluid exchange apparatus
US8911227B2 (en) * 2012-01-11 2014-12-16 Johnson & Johnson Vision Care, Inc. Device for injection molding silicone rubber
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
FR2986703B1 (en) * 2012-02-09 2015-01-16 Horus Pharma DEVICE FOR PACKAGING AND DISPENSING A PRODUCT FOR OPHTHALMIC USE
CA2872338C (en) 2012-05-03 2021-09-14 Qlt Inc. Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
RU2520834C2 (en) * 2012-09-11 2014-06-27 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Профессионального Образования "Дагестанский Государственный Технический Университет" (Дгту) Method for preventing and treating dry eye syndrome
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
CN112932781A (en) 2013-01-15 2021-06-11 科罗拉多州立大学董事会, 公司实体 Lacrimal system drug delivery device
WO2014152959A1 (en) 2013-03-14 2014-09-25 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
CA2907881A1 (en) * 2013-03-27 2014-10-02 Forsight Vision5, Inc. Bimatoprost ocular silicone inserts and methods of use thereof
CA2907681C (en) 2013-03-28 2022-11-22 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
EP3057514A4 (en) * 2013-10-15 2017-08-02 Forsight Vision5, Inc. Formulations and methods for increasing or reducing mucus
EP3677229A1 (en) 2014-05-29 2020-07-08 Glaukos Corporation Implants with controlled drug delivery features
RU2557423C1 (en) * 2014-06-25 2015-07-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт глазных болезней" (ФГБНУ "НИИ глазных болезней") Method of treating partial dacryostenosis
AU2015289625B2 (en) 2014-07-15 2019-10-10 Forsight Vision4, Inc. Ocular implant delivery device and method
KR20170040798A (en) 2014-08-08 2017-04-13 포사이트 비젼4, 인크. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
CN110478119B (en) 2014-11-10 2022-04-15 弗赛特影像4股份有限公司 Expandable drug delivery device and method of use
EP3223793B1 (en) * 2014-11-25 2023-06-28 Eximore Ltd. Compositions and methods for delivering a bio-active agent or bio-active agents
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
CN106264777A (en) * 2015-06-08 2017-01-04 三鼎生物科技股份有限公司 Auxiliary dacryagogue
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US10092387B2 (en) * 2015-09-24 2018-10-09 California Institute Of Technology Implantable device for retaining live cells and providing nutrients thereto
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN108430405B (en) 2015-11-20 2021-04-13 弗赛特影像4股份有限公司 Porous structures for sustained release drug delivery devices
WO2017091404A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
EP3439591B1 (en) 2016-04-05 2020-09-23 ForSight Vision4, Inc. Implantable ocular drug delivery devices
CN115120405A (en) 2016-04-20 2022-09-30 多斯医学公司 Delivery device for bioabsorbable ocular drugs
AU2017268379A1 (en) 2016-05-20 2018-12-06 The Regents Of The University Of Colorado, A Body Corporate Lacrimal drug delivery device
CN106667656A (en) * 2016-06-30 2017-05-17 广州聚明生物科技有限公司 Biodegradable lacrimal passage suppository and preparation method and application thereof
CA3065474A1 (en) * 2017-05-30 2018-12-06 Eximore Ltd. Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide
CA3082891A1 (en) 2017-11-21 2019-05-31 Forsight Vision4, Inc. Fluid exchange apparatus for expandable port delivery system and methods of use
US20220125637A1 (en) * 2019-01-18 2022-04-28 Avisi Technologies, Inc. Method and device for treating eye disease
KR102414314B1 (en) * 2019-02-27 2022-06-30 사회복지법인 삼성생명공익재단 Implant for ophthalmopathy comprising coating layer

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949750A (en) 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3992518A (en) 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4053580A (en) 1975-01-01 1977-10-11 G. D. Searle & Co. Microsealed pharmaceutical delivery device
FR2534580A1 (en) 1982-10-13 1984-04-20 Synthelabo PHENYL-1 PIPERIDINO-2 PROPANOL DERIVATIVES, THEIR PREPARATION, AND MEDICINES THAT CONTAIN THEM
US4660546A (en) 1984-11-07 1987-04-28 Robert S. Herrick Method for treating for deficiency of tears
US5053030A (en) 1984-11-07 1991-10-01 Herrick Robert S Intracanalicular implant for horizontal canalicular blockade treatment of the eye
US5049142A (en) 1984-11-07 1991-09-17 Herrick Robert S Intracanalicular implant for horizontal canalicular blockade treatment of the eye
US5151444B1 (en) 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
US4923699A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US4915684A (en) 1988-06-21 1990-04-10 Mackeen Donald L Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE420857T1 (en) 1988-09-06 2009-01-15 Pfizer Health Ab PROSTAGLANDIN DERIVATIVES FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION
SU1671295A1 (en) * 1988-10-24 1991-08-23 Туркменский государственный медицинский институт Appliance for control of intraocular pressure in case of glaucoma
US4959048A (en) 1989-01-17 1990-09-25 Helix Medical, Inc. Lacrimal duct occluder
US5067491A (en) * 1989-12-08 1991-11-26 Becton, Dickinson And Company Barrier coating on blood contacting devices
US5163959A (en) 1990-03-29 1992-11-17 Herrick Robert S Method for treating an eye with a canalicular implant having a collapsible flared section
US5171270A (en) 1990-03-29 1992-12-15 Herrick Robert S Canalicular implant having a collapsible flared section and method
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5283063A (en) 1992-01-31 1994-02-01 Eagle Vision Punctum plug method and apparatus
ATE207360T1 (en) 1992-03-19 2001-11-15 R Tech Ueno Ltd TREATMENT OF EYE HYPERTENSION WITH BETA BLOCKERS AND PROSTONE ACID DERIVATIVES
US5469867A (en) 1992-09-02 1995-11-28 Landec Corporation Cast-in place thermoplastic channel occluder
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5922773A (en) 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5417651A (en) 1993-07-01 1995-05-23 Guena; Nicolas Punctum plug and monocanalicular probe for lacrimal pathology
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
AU7668894A (en) 1993-08-13 1995-03-14 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
US5423777A (en) 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
JP3486758B2 (en) 1994-06-24 2004-01-13 株式会社高研 Injectable lacrimal canaliculus
US6149684A (en) 1995-06-07 2000-11-21 Herrick; Robert S. Punctum plug having a thin elongated lip and a distal starting tip and method of using
US5723005A (en) 1995-06-07 1998-03-03 Herrick Family Limited Partnership Punctum plug having a collapsible flared section and method
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5741292A (en) 1995-10-26 1998-04-21 Eagle Vision Punctum dilating and plug inserting instrument with push-button plug release
JP3792775B2 (en) 1996-04-08 2006-07-05 有限会社エム・エル・シー Lacrimal intubation device
JPH1033584A (en) 1996-07-26 1998-02-10 M L C:Kk Lacrimal duct insertion appliance
US6027470A (en) 1998-06-10 2000-02-22 Eagle Vision, Inc. Punctum plug and method for inserting the same into the punctual opening
US6041785A (en) 1997-03-27 2000-03-28 Eaglevision, Inc. Punctum plug
US6016806A (en) 1997-03-27 2000-01-25 Eaglevision, Inc Punctum plug
US5830171A (en) 1997-08-12 1998-11-03 Odyssey Medical, Inc. Punctal occluder
NL1008090C2 (en) 1998-01-22 1999-07-26 Lubberman Bernardus H M Plug for closing a tear duct.
US6290684B1 (en) 1998-03-02 2001-09-18 Herrick Family Limited Partnership Punctum plug having a collapsible expanded section and distal tip extending substantially perpendicular thereto and method of inserting same
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6306114B1 (en) 1998-06-16 2001-10-23 Eagle Vision, Inc. Valved canalicular plug for lacrimal duct occlusion
US20020022055A1 (en) 1999-02-23 2002-02-21 Signore Pierre E Composition and methods for immproving integrity of compromised body passageways and cavities
US6234175B1 (en) 1999-03-23 2001-05-22 Medennium, Inc. Smart ocular plug design and method of insertion for punctal and intracanalicular implants
US6383192B1 (en) 1999-04-28 2002-05-07 Mlc Limited Company Apparatus for intubation of lacrimal duct
US6344047B1 (en) 2000-02-02 2002-02-05 Eagle Vision Instrument for inserting a punctum plug and method for manufacturing the instrument
ES2231306T3 (en) 2000-08-04 2005-05-16 Medennium, Inc. OCULAR PLUG TO IMPLEMENT IN THE LAGRIMAL POINT AND THE CHANNEL.
EP1372602B1 (en) 2001-01-09 2007-04-18 Microchips, Inc. Flexible microchip devices for ophthalmic and other applications
US6827738B2 (en) * 2001-01-30 2004-12-07 Timothy R. Willis Refractive intraocular implant lens and method
US6685626B2 (en) 2001-02-02 2004-02-03 Regeneration Technologies, Inc. Compositions, devices, methods, and kits for induction of adhesions
JP2002263124A (en) 2001-03-12 2002-09-17 Masashige Nakayama Eye disease treating method for animal and artificial lachrymal duct used therefor
US6605108B2 (en) * 2001-04-13 2003-08-12 Eagle Vision, Inc. Monocanalicular stent
US20040022853A1 (en) 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
US7404825B2 (en) 2001-06-11 2008-07-29 Herrick Ii Robert S Implant capable of forming a differential image in an eye
DE10133870A1 (en) 2001-07-12 2003-02-06 Chris P Lohmann Ophthalmic agent, use of EGF for the treatment of dry eye syndrome and insert for the administration of EGF to the eye
US7204995B2 (en) 2002-01-31 2007-04-17 El-Sherif Dalia M Treatment and control of dry eye by use of biodegradable polymer capsules
US20040043067A1 (en) * 2002-06-19 2004-03-04 Salamone Joseph C. Fluorosiloxane matrix controlled diffusion drug delivery systems
PL206594B1 (en) 2002-07-15 2010-08-31 Alcon Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
FR2844182B1 (en) 2002-09-11 2004-12-03 Humanoptics Ag CLOSURE PLUG OF A LACRYMAL CANALICLE
CA2497349C (en) 2002-09-26 2008-07-08 Angiotech International Ag Perivascular wraps
BRPI0406858A (en) 2003-01-24 2006-01-03 Control Delivery Sys Inc Controlled release of highly soluble agents
MXPA05007718A (en) 2003-01-24 2005-09-30 Control Delivery Sys Inc Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors.
US8021680B2 (en) * 2003-05-02 2011-09-20 Surmodics, Inc. Controlled release bioactive agent delivery device
EP1682196A2 (en) * 2003-11-10 2006-07-26 Angiotech International Ag Medical implants and anti-scarring agents
US20050232972A1 (en) 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US7799336B2 (en) * 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US7252006B2 (en) * 2004-06-07 2007-08-07 California Institute Of Technology Implantable mechanical pressure sensor and method of manufacturing the same
EP3093040A1 (en) 2004-07-02 2016-11-16 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
US7117870B2 (en) 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
US7575781B2 (en) * 2004-08-03 2009-08-18 Sur Modics, Inc. Method for depositing a polymeric coating on a substrate
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods
NZ571758A (en) 2006-03-31 2012-06-29 Quadra Logic Tech Inc A drug insert surrounded by a sheath to expose a polymer containing a drug to surrounding tissues or an eye
US9173773B2 (en) 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US9474645B2 (en) 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US20080045911A1 (en) 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
US20080086101A1 (en) 2006-08-25 2008-04-10 David Freilich Ophthalmic insert

Also Published As

Publication number Publication date
SI2114531T1 (en) 2012-09-28
AU2008210541A1 (en) 2008-08-07
CA2674913A1 (en) 2008-08-07
US8753666B2 (en) 2014-06-17
UY30883A1 (en) 2008-05-31
PT2114531E (en) 2012-10-09
CL2008000306A1 (en) 2008-09-05
ES2390991T3 (en) 2012-11-20
KR20090104099A (en) 2009-10-05
RU2459646C2 (en) 2012-08-27
EP2114531B1 (en) 2012-07-11
JP2010517630A (en) 2010-05-27
HRP20120608T1 (en) 2012-08-31
HK1133218A1 (en) 2010-03-19
AU2008210541B2 (en) 2013-09-26
PL2114531T3 (en) 2012-10-31
EP2114531A2 (en) 2009-11-11
RU2009132493A (en) 2011-03-10
BRPI0807340A2 (en) 2017-05-02
AR065235A1 (en) 2009-05-27
WO2008094989A2 (en) 2008-08-07
TW200838485A (en) 2008-10-01
CN101600476B (en) 2013-08-21
WO2008094989A3 (en) 2009-04-30
CY1113075T1 (en) 2016-04-13
DK2114531T3 (en) 2012-07-30
CN101600476A (en) 2009-12-09
US20080181930A1 (en) 2008-07-31
MX2009007394A (en) 2009-08-12

Similar Documents

Publication Publication Date Title
HK1133218A1 (en) Punctal plugs and methods of delivering therapeutic agents
IL202684A0 (en) Anti-cd20 therapeutic compositions and methods of use thereof
IL210385A0 (en) Ophthalmic device having therapeutic agent delivery capability and method of forming same
GB2461412B (en) Methods and compositions for reduction of side effects of therapeutic treatments
IL242268A0 (en) Combinations and modes of administration of therapeutic agents and combination therapy
ZA200901842B (en) Ocular devices and methods of making and using thereof
IL202611A0 (en) Methods of treating serotonin-mediated diseases and disorders
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP2152304A4 (en) Nanoemulsion therapeutic compositions and methods of using the same
EP2448581A4 (en) Therapeutic compositions and related methods of use
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EP2268281A4 (en) Thienopyrroles and pyrrolothiazoles as new therapeutic agents
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL206891A0 (en) Therapeutic inhibitors of pai-1 function and methods of their use
HK1142823A1 (en) Formulations for the oral administration of therapeutic agents and related methods
EP2440205A4 (en) Iminosugars and methods of treating bunyaviral and togaviral diseases
EP2049899A4 (en) Methods to prevent and treat diseases
PL2121025T3 (en) Methods and compositions for the delivery of a therapeutic agent
SG138567A1 (en) Punctal plugs for the delivery of active agents
SG138565A1 (en) Punctal plugs for the delivery of active agents
EP2473046A4 (en) Iminosugars and methods of treating filoviral diseases
EP1988889A4 (en) Compositions and methods for treatment of ophthalmic diseases and disorders
ZA200903653B (en) Methods for treatment of cochlear and vestibular disorders
SG138564A1 (en) Punctal plugs for the delivery of active agents
GB201108289D0 (en) Therapeutic garment and method of providing therapy using the same